This content is from: Premium

Jeffrey Ubben on Disclosure and the Costs of Notoriety

The founder of activist fund ValueAct laments the effect news of stock purchases has on price and wonders why many activists get so much credit.

Call it the risk and reward of notoriety and success. Since he launched his activist hedge fund firm, ValueAct Capital, in San Francisco in 2000, Jeffrey Ubben has mostly kept a low profile. (I did write about him in 2005 and have been covering him ever since.) The onetime Fidelity analyst, who

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content